BMRN BioMarin Pharmaceutical Inc. | US09061G1013
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 11.467.566.080 | 10.917.758.790,7 | 11.428.395.061,12 | 10.404.068.324,85 |
| Enterprise Value | 10.684.731.392 | 10.134.924.790,7 | 10.722.577.061,12 | 9.758.201.324,85 |
| Trailing P/E | 42,68 | 40,63 | 32,76 | 26,31 |
| Forward P/E | 9,28 | - | - | - |
| Price to Sales | 3,54 | 3,37 | 3,55 | 4,43 |
| Price to Book | 1,85 | 1,76 | 1,88 | 1,72 |
| EV/Revenue | 3,3 | 3,13 | 3,33 | 4,16 |
| EV/EBITDA | 16,93 | 21,01 | 18,72 | 16,92 |